All persons or entities that purchased or otherwise acquired the common stock of Emergent BioSolutions Inc. (“Emergent”) (NYSE: EBS) between March 10, 2020 and November 4, 2021, both dates inclusive.
Preliminarily Approved
March 09, 2020 - February 02, 2022
February 27, 2025
February 04, 2025
Strategic Claims Services
P.O. Box 230, 600 N. Jackson St., Ste. 205 Media, PA 19063
+1 866-274-4004
info@strategicclaims.net
Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.